StockData
NUTXNasdaqServices-Business Services, NECFiscal year ends December 31

Nutex Health Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$191.25+5.15 (+2.77%)

Close on Oct 19, 2026

Market cap
$1.34B
P/E (TTM)
7.5
Dividend yield
–

About Nutex Health

Services-Business Services, NEC, SIC 7389

Nutex Health Inc. is a physician-led healthcare services and operations company. It structures its operations into three primary segments: the hospital division, the population health management division, and the real estate division. Through its hospital division, the company develops and operates micro-hospitals, specialty hospitals, and hospital outpatient departments that provide emergency room care, inpatient treatment, behavioral health, and ancillary services including diagnostic imaging, laboratories, and onsite pharmacies. The population health management division organizes and manages provider networks known as independent physician associations via a management services organization. The company serves patients seeking emergency and primary medical care, receiving reimbursement primarily from health insurers, federal agencies, and patient cost-sharing payments.

The company operates 26 healthcare facilities across 12 U.S. states and oversees four independent physician associations serving members across California, Florida, Texas, and Arizona. Its operational workforce comprises 944 full-time employees, over 280 contracted facility doctors, and partnerships with more than 3,600 network physicians and specialists. Nutex Health maintains its corporate headquarters in Houston, Texas.

Summary of the business section of Nutex Health's latest annual report, written by StockData.

Company profile

Company

Legal name
Nutex Health Inc.
Founded
2000
Headquarters
Houston, TX
Address
1776 Yorktown St, Suite 700 77056
Phone
(713) 660-0557
Employees
944, Dec 31, 2025
Industry
Services-Business Services, NEC
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Marcum LLP, Houston, Texas

Stock & identifiers

Ticker
NUTX
Exchange
Nasdaq
Shares outstanding
7M, Aug 4, 2026
Public float
$524.00M, Jun 30, 2025
Filer category
Accelerated filer
Stock splits
1-for-10 reverse, Jul 3, 2024; 1-for-10 reverse, Jul 2, 2024; 1-for-15 reverse, Apr 10, 2024; 1-for-15 reverse, Apr 9, 2024; 20-for-1, Aug 22, 2022; 1-for-500 reverse, Nov 19, 2019
SEC CIK
1479681
CUSIP
67079U306
ISIN
US67079U3068
LEI
254900RSD2OET3HENJ50
EIN
11-3363609

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Thomas T. VoChief Executive Officer, Director28,809,974
Warren HosseinionPresident, Director61,739
Wesley Shane BamburgChief Operating Officer–
Pamela W. MontgomeryChief Legal Officer-Healthcare2,758
Michael L. ChangChief Medical Officer82,356
Elisa V. LuqmanChief Legal Officer - SEC4,224
Jon Christian BatesChief Financial Officer8,305
Joshua DeTillioChief Operating Officer6,481
Scott J. SaundersDirector400
Cheryl Yvonne GrenasDirector10,670
Frank E. JaumotDirector753
Michael Lee ReedDirector670
Kelvin SpearsDirector34,656

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Thomas T. Vo
$1.94M$4.60M$787.81K$58$122
FY2024
Thomas T. Vo
$1.16M$1.56M$912.23K$11$106
FY2023
Thomas T. Vo
$1.02M$1.02M$577.39K$9$103
FY2023
Tom Vo
$1.01M$1.01M$577.39K$9$103
FY2022
Dr Hosseinion
$2.67M$2.19M$419.42K$-450–
FY2022
Dr Vo
$938.23K$938.23K$419.42K$-450–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

Corporate history

Events identified from SEC filings

DateEventDetails
Sep 22, 2026ListingRegistration of securities on an exchange (Form 8-A)
Nov 17, 2025Late filingNotification of late filing
Oct 20, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 21, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 14, 2025Late filingNotification of late filing
May 21, 2025Auditor changeChange in certifying accountant (8-K Item 4.01)
Apr 25, 2025Auditor changeChange in certifying accountant (8-K Item 4.01)
Jun 18, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 24, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Mar 15, 2024Late filingNotification of late filing
Nov 27, 2023Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 26, 2023Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 11, 2023Late filingNotification of late filing
Mar 2, 2023Late filingNotification of late filing
Nov 15, 2022Late filingNotification of late filing
Aug 15, 2022Late filingNotification of late filing
Jun 16, 2022Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 4, 2022Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 31, 2022Name changeName changed from Clinigence Holdings, Inc. to Nutex Health, Inc.
Mar 31, 2022ListingRegistration of securities on an exchange (Form 8-A)
Feb 14, 2022Merger voteDefinitive merger proxy statement
Oct 21, 2021Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
May 17, 2021Late filingNotification of late filing
Apr 1, 2021Late filingNotification of late filing
Mar 5, 2021Auditor changeChange in certifying accountant (8-K Item 4.01)
Mar 2, 2021Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 14, 2020Late filingNotification of late filing
Jun 3, 2020Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 30, 2020Late filingNotification of late filing
Nov 14, 2019Late filingNotification of late filing